Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2016 Jun;101(6):747-56.
doi: 10.3324/haematol.2015.140053. Epub 2016 Mar 11.

Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study

Affiliations
Multicenter Study

Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study

Claire Oudin et al. Haematologica. 2016 Jun.

Abstract

Thyroid complications are known side effects of irradiation. However, the risk of such complications in childhood acute leukemia survivors who received either central nervous system irradiation or hematopoietic stem cell transplantation is less described. We prospectively evaluated the incidence and risk factors for thyroid dysfunction and tumors in survivors of childhood acute myeloid or lymphoid leukemia. A total of 588 patients were evaluated for thyroid function, and 502 individuals were assessed for thyroid tumors (median follow-up duration: 12.6 and 12.5 years, respectively). The cumulative incidence of hypothyroidism was 17.3% (95% CI: 14.1-21.1) and 24.6% (95% CI: 20.4-29.6) at 10 and 20 years from leukemia diagnosis, respectively. Patients who received total body irradiation (with or without prior central nervous system irradiation) were at higher risk of hypothyroidism (adjusted HR: 2.87; P=0.04 and 2.79, P=0.01, respectively) as compared with transplanted patients who never received any irradiation. Patients transplanted without total body irradiation who received central nervous system irradiation were also at higher risk (adjusted HR: 3.39; P=0.02). Patients irradiated or transplanted at older than 10 years of age had a lower risk (adjusted HR: 0.61; P=0.02). Thyroid malignancy was found in 26 patients (5.2%). Among them, two patients had never received any type of irradiation: alkylating agents could also promote thyroid cancer. The cumulative incidence of thyroid malignancy was 9.6% (95% CI: 6.0-15.0) at 20 years. Women were at higher risk than men (adjusted HR: 4.74; P=0.002). In conclusion, thyroid complications are frequent among patients who undergo transplantation after total body irradiation and those who received prior central nervous system irradiation. Close monitoring is thus warranted for these patients. Clinicaltrials.gov identifier: NCT 01756599.

Trial registration: ClinicalTrials.gov NCT01756599.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Cumulative incidences of hypothyroidism. (A) Cumulative incidence of hypothyroidism; impact of transplantation and irradiation type. (P<10−3). (B) Cumulative incidence of hypothyroidism in patients treated with hematopoietic stem cell transplantation without total body irradiation (n=135): comparison between patients who received prior central nervous system irradiation and patients who did not (P=0.005). (C) Cumulative incidence of hypothyroidism among patients treated with hematopoietic stem cell transplantation who received total body irradiation as part of their conditioning: comparison between patients who were exposed to central nervous system irradiation and those who were not (P=non significant). HSCT: hematopoietic stem cell transplantation; CNS: central nervous system. TBI: total body irradiation.
Figure 2.
Figure 2.
Cumulative incidence of thyroid cancer. The figure shows the cumulative incidence of thyroid cancer in the whole cohort (green line), and a comparison of the incidence between females (blue line) and males (red line). P<0.001.

References

    1. Pui CH, Pei D, Sandlund JT, et al. Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. J Clin Oncol. 2005;23(31):7936–7941. - PubMed
    1. de Fine Licht S, Winther JF, Gudmundsdottir T, et al. Hospital contacts for endocrine disorders in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): a population-based cohort study. Lancet. 2014;383(9933): 1981–1989. - PubMed
    1. Carter EP, Leiper AD, Chessells JM, Hurst A. Thyroid function in children after treatment for acute lymphoblastic leukaemia. Arch Dis Child. 1989;64(4):631. - PMC - PubMed
    1. Chow EJ, Friedman DL, Stovall M, et al. Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor study. Pediatr Blood Cancer. 2009;53(3):432–437. - PMC - PubMed
    1. Lando A, Holm K, Nysom K, et al. Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation. Clin Endocrinol (Oxf). 2001;55(1):21–25. - PubMed

Publication types

MeSH terms

Associated data